Results 71 to 80 of about 4,356 (162)

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF

JACC: Heart Failure
في حين أنه لا يوصى باستخدام حاصرات بيتا لعلاج HFpEF وفقًا لأحدث إرشادات ESC و AHA/ACC/HFSA، إلا أن هذه العلاجات لا تزال شائعة الاستخدام لإدارة الاعتلال المشترك. كان هناك قلق من أن حاصرات بيتا قد تؤثر سلبًا على النتائج السريرية من خلال الحد من الاستجابة الكرونوتروبية في HFpEF.
Alexander Peikert, Bradley A. Bart, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Mikhail Kosiborod, Akshay S. Desai, Pardeep S. Jhund, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Rudolf A. de Boer, Adrian F. Hernandez, Sanjiv J. Shah, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon, Orly Vardeny   +18 more
openaire   +1 more source

Obesity Paradox in Heart Failure with Mildly Reduced Ejection Fraction

Pragmatic and Observational Research
Marielen Reinhardt,1,* Tobias Schupp,1,* Mohammad Abumayyaleh,1 Felix Lau,1,2 Alexander Schmitt,1 Noah Abel,1 Muharrem Akin,2 Jonas Rusnak,3 Ibrahim Akin,1 Michael Behnes1 1Department of Cardiology, Angiology, Haemostaseology and Medical ...
Reinhardt M, Schupp T, Abumayyaleh M, Lau F, Schmitt A, Abel N, Akin M, Rusnak J, Akin I, Behnes M   +9 more
doaj  

P2457Left atrial strain parameters predict clinical outcomes in patients with HFmrEF and HFpEF

European Heart Journal, 2019
Abstract Background Heart failure with preserved ejection fraction (HFpEF) and with mid-range ejection fraction (HFmrEF) are conditions sharing similar diagnostic criteria and symptoms. Left ventricular (LV) diastolic dysfunction has often been considered central to the pathophysiology of both, as ...
A Vrettos, L Al Saikhan, L Matiti, C Plymen, B Low, P Nihoyannopoulos   +5 more
openaire   +1 more source

Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction

ESC Heart Failure
Aims Endogenous catecholamine release‐inhibitory peptide catestatin has been associated with heart failure (HF). This subgroup analysis of our cohort of HF compared the different effects of catestatin as a predictor for cardiac outcomes in patients with ...
Song‐Yun Chu, Fen Peng, Jie Wang, Lin Liu, Jing Zhao, Xiao‐Ning Han, Wen‐Hui Ding   +6 more
doaj   +1 more source

Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER Trial.

JACC. Heart failure, 2023
Although beta-blockers are not recommended for the treatment of heart failure with preserved ejection fraction (HFpEF) according to the latest European Society of Cardiology and American Heart Association/American College of Cardiology/Heart Failure Society of America guidelines, these therapies remain commonly used for comorbidity management.
Peikert, Alexander, Bart, Bradley A., Vaduganathan, Muthiah, Claggett, Brian L., Kulac, Ian J., Kosiborod, Mikhail N., Desai, Akshay S., Jhund, Pardeep S., Lam, Carolyn S.P., Inzucchi, Silvio E., Martinez, Felipe A., de Boer, Rudolf A., Hernandez, Adrian F., Shah, Sanjiv J., Petersson, Magnus, Langkilde, Anna Maria, McMurray, John J.V., Solomon, Scott D., Vardeny, Orly   +18 more
openaire   +3 more sources

LV Strain Superiority Over LVEF in HFmrEF

JACC: Advances, 2023
Giuseppe Galati, Olga Germanova, Roberto Franco Enrico Pedretti   +2 more
openaire   +1 more source

HFmrEF: Közepes ejekciós frakciójú szívelégtelenség [PDF]

Cardiologia Hungarica, 2019
openaire   +2 more sources

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies

Frontiers in Cardiovascular Medicine
IntroductionThe influence of sex on the prognosis of heart failure with preserved or intermediate ejection fraction (HFpEF and HFmrEF) remains uncertain.
You Deng, Jun Zhang, Jitao Ling, Qingwen Hu, Tianggang Song, Yi Xu, Menglu Liu, Yuting Wu, Kaibo Mei, Jiawei Chen, Huilei Zhao, Xiao Liu   +11 more
doaj   +1 more source

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study

ESC Heart Failure, 2019
Aim The factors correlated with prognosis in heart failure with mid‐range ejection fraction (HFmrEF) is unclear, especially for acute heart failure (AHF) with HFmrEF.
Kyosuke Yanagawa, Hitoshi Nakamura, Yutaka Matsuhiro, Koji Yasumoto, Keisuke Yasumura, Akihiro Tanaka, Yasuharu Matsunaga‐Lee, Daisuke Nakamura, Masamichi Yano, Masaki Yamato, Yasuyuki Egami, Ryu Shutta, Yasushi Sakata, Masami Nishino, Jun Tanouchi   +14 more
doaj   +1 more source

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction

Frontiers in Cardiovascular Medicine
BackgroundHeart failure with mildly reduced ejection fraction (HFmrEF) has emerged as the predominant subtype of heart failure (HF). This study aimed to develop artificial intelligence (AI)-electrocardiography (ECG) to identify and predict the prognosis ...
Dae-Young Kim, Sang-Won Lee, Dong-Ho Lee, Sang-Chul Lee, Sang-Chul Lee, Ji-Hun Jang, Sung-Hee Shin, Dae-Hyeok Kim, Dae-Hyeok Kim, Wonik Choi, Wonik Choi, Yong-Soo Baek, Yong-Soo Baek, Yong-Soo Baek   +13 more
doaj   +1 more source